Literature DB >> 23194495

Pexelizumab fails to inhibit assembly of the terminal complement complex in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention. Insight from a substudy of the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) trial.

Gen-Min Lin, Yi-Hwei Li, Lamin E S Jaiteh, Chih-Lu Han.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23194495     DOI： 10.1016/j.ahj.2012.09.012

Source DB:  PubMed          Journal:  Am Heart J        ISSN： 0002-8703            Impact factor:   4.749


× No keyword cloud information.
  3 in total

Review 1.  Autophagy, a process within reperfusion injury: an update.

Authors:  Bisharad Anil Thapalia; Zhen Zhou; Xianhe Lin
Journal:  Int J Clin Exp Pathol       Date:  2014-12-01

Review 2.  Leukocyte diversity in resolving and nonresolving mechanisms of cardiac remodeling.

Authors:  Bochra Tourki; Ganesh Halade
Journal:  FASEB J       Date:  2017-06-22       Impact factor: 5.191

3.  Therapeutic effects of percutaneous coronary intervention on acute myocardial infarction complicated with multiple organ dysfunction syndrome.

Authors:  Dajun Qian; Daqiong Zhou; Huan Liu; Di Xu
Journal:  Pak J Med Sci       Date:  2019 Nov-Dec       Impact factor: 1.088
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.